Merck and AstraZeneca Present Final Results of Key Secondary Overall Survival Endpoint From Phase 3 PROpel Trial at 2023 American Society of Clinical Oncology Genitourinary Cancers Symposium Life Science Investing
Pfizer Announces Positive TALZENNA® and XTANDI® Combination Data from Phase 3 TALAPRO-2 Study Life Science Investing
Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Campaign to Raise Awareness of Atrial Fibrillation and its Symptoms Pharmaceutical Investing
Pfizer Announces The Lancet Neurology Has Published Phase 3 Data for Zavegepant for the Acute Treatment of Migraine in Adults Life Science Investing
Seelos Therapeutics to Participate in 43rd Annual Cowen Health Care Conference Psychedelics Investing
Johnson & Johnson Names Paula A. Johnson, President of Wellesley College, to its Board of Directors Pharmaceutical Investing
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NUVASIVE , Oak Street Health , Argo Group International Holdings, Ltd. , Cardiovascular Systems, Inc. Pharmaceutical Investing
Medtronic to announce financial results for its third quarter of fiscal year 2023 Medical Device Investing
Gilead Demonstrates Transformative Potential Impact Of Antiviral Innovation at CROI 2023 Pharmaceutical Investing
